Simulations Plus Inc

Insider buying at Simulations Plus (SPMI) shows growing confidence and could spark a bullish turn—discover what this means for its drug‑simulation tech and future earnings.

Insider buy of 1,776 shares by Evans Sharlene at zero cost shows confidence in Simulations Plus, a niche simulation software firm amid a volatile market and emerging defense opportunities.